Drug Sheets Erin Graded

Rogers State University Associate Degree Nursing Program Required Drug Information Student name:

ERIN MCDANIEL

Date/ Clinical week:

11/02/2009- WEEK 2

Clinical faculty:

Mrs. VAN GUNDY

Patient weight:

39.5 #

Patient age:

4

Patient allergies

NKDA

1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects:

5. 6. 7.

8.

9.

Common adverse reactions/side effects:

What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication?

IBUPROFEN Children's Motrin Chronic, symptomatic rheumatoid arthritis and osteoarthritis; relief of mild to moderate pain; primary dysmenorrhea; reduction of fever For pain Pain relief Yes, pt had pain from constant cough. Pain was not present when asked around an hour after administered. Hypertension, history of GI ulceration; diabetes mellitus, impaired hepatic or renal function, history of coronary artery disease, angina, MI cardiac decompensation; chronic renal failure, patients with SLE. CNS: Headache, dizziness, light-headedness, anxiety, emotional lability, fatigue, malaise, drowsiness, anxiety, confusion, depression, aseptic meningitis. CV: Hypertension, palpitation, congestive heart failure (patient with marginal cardiac function); peripheral edema. Special Senses: Amblyopia (blurred vision, decreased visual acuity, scotomas, changes in color vision); nystagmus, visual-field defects; tinnitus, impaired hearing. GI: Dry mouth, gingival ulcerations, dyspepsia, heartburn, nausea, vomiting, anorexia, diarrhea, constipation, bloating, flatulence, epigastric or abdominal discomfort or pain, GI ulceration, occult blood loss. Hematologic: Thrombocytopenia, neutropenia, hemolytic or aplastic anemia, leukopenia; decreased Hgb, Hct; transitory rise in AST, ALT, serum alkaline phosphatase; rise in (Ivy) bleeding time. GU: Acute renal failure, polyuria, azotemia, cystitis, hematuria, nephrotoxicity, decreased creatinine clearance. Skin: Maculopapular and vesicobullous skin eruptions, erythema multiforme, pruritus, rectal itching, acne. Body as a Whole: Fluid retention with edema, Stevens-Johnson syndrome, toxic hepatitis, hypersensitivity reactions, anaphylaxis, bronchospasm, serum sickness, SLE, angioedema. 90-180mg q4-6h up to 720mg/d Yes, 7.5ml every 6 hrs prn for pain Observation for apnea, cyanosis, dizziness, and nystagmus.

12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

Baseline and periodic evaluations of Hgb, renal and hepatic function, and auditory and ophthalmologic examinations are recommended in patients receiving prolonged or high-dose therapy. Discontinue med immediately and notify physician if apnea, cyanosis, dizziness, and/or nystagmus is present in patient. Notify physician immediately of passage of dark tarry stools, "coffee ground" emesis, frankly bloody emesis, or other GI distress, as well as blood or protein in urine, and onset of skin rash, pruritus, jaundice.

Rogers State University Associate Degree Nursing Program Required Drug Information Student name:

ERIN MCDANIEL

Date/ Clinical week:

11/02/2009- Week 2

Clinical faculty:

Mrs. VAN GUNDY

Patient weight:

39.5#

Patient age: Patient allergies 1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects:

5. 6. 7.

8.

Common adverse reactions/side effects:

9.

What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication? 12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

4 NKDA ACETAMINOPHEN Tylenol Suspension 160/5 It provides temporary analgesia for mild to moderate pain. In addition, acetaminophen lowers body temperature in individuals with a fever. If fever present. To reduce fever Pt did not receive. Fever was not present. Repeated administration to patients with anemia, G6PD deficiency, renal or hepatic disease; arthritic or rheumatoid conditions affecting children <12 y; alcoholism; malnutrition; thrombocytopenia; bone marrow depression, immunosuppression. Body as a Whole: Negligible with recommended dosage; rash. Acute poisoning: Anorexia, nausea, vomiting, dizziness, lethargy, diaphoresis, chills, epigastric or abdominal pain, diarrhea; onset of hepatotoxicity—elevation of serum transaminases (ALT, AST) and bilirubin; hypoglycemia, hepatic coma, acute renal failure (rare). Chronic ingestion: Neutropenia, pancytopenia, leukopenia, thrombocytopenic purpura, hepatotoxicity in alcoholics, renal damage. 180-270 mg q4-6h Yes, 7.5ml q4-6 hrs prn for fever. Monitor for hepatotoxicity, even with moderate acetaminophen doses, especially in individuals with poor nutrition, and poisoning. n/a Discontinue med immediately and notify physician if any signs of hepatotoxicity signs present. Do not use this medication without medical direction for: fever persisting longer than 3 d, fever over 39.5° C (103° F), or recurrent fever. Do not take other medications (e.g., cold preparations) containing acetaminophen without medical advice; overdosing and chronic use can cause liver damage and other toxic effects.

Rogers State University Associate Degree Nursing Program Required Drug Information Student name: Date/ Clinical week:

ERIN MCDANIEL 11/02/2009

Clinical faculty:

VAN GUNDY

Patient weight:

39.5#

Patient age: Patient allergies 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13.

14.

Generic name of the drug: Trade name of the drug: Indications for use of the drug: For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects: Common adverse reactions/side effects: What is the normal dose range of the medication for this patient? Is this patient's dose within the normal range? What special nursing assessments are required for patients receiving this medication? What lab tests are monitored related to use of this medication? What special nursing interventions are required for patients receiving this medication? What special teaching is required for patients receiving this medication?

4 NKDA AZITHROMYCIN Zithromax Acute bacterial sinusitis and community acquired pneumonia Community acquired pneumonia To clear up pneumonia Not after day 2. Pt’s pneumonia has gotten worse. Toxicity CNS: Headache, dizziness. GI: Nausea, vomiting, diarrhea, abdominal pain; hepatotoxicity, mild elevations in liver function tests. 180 mg on day 1, then 90 mg for 4 more days (max: 250 mg/d) No, 200 mg po every day (dose slightly over, but under daily max) Monitor for and report loose stools or diarrhea, since pseudomembranous colitis must be ruled out. n/a Discontinue med and notify physician if any signs of diarrhea, nausea, or vomiting occur. Direct sunlight (UV) exposure should be minimized during therapy with drug. Report onset of loose stools or diarrhea.

Rogers State University Associate Degree Nursing Program Required Drug Information Student name:

ERIN MCDANIEL

Date/ Clinical week:

11/02/2009- Week 2

Clinical faculty:

Mrs. Van Gundy

Patient weight:

39.5#

Patient age: Patient allergies 1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects: Common adverse reactions/side effects:

5. 6. 7. 8.

9. 10. 11. 12. 13.

14.

What is the normal dose range of the medication for this patient? Is this patient's dose within the normal range? What special nursing assessments are required for patients receiving this medication? What lab tests are monitored related to use of this medication? What special nursing interventions are required for patients receiving this medication? What special teaching is required for patients receiving this medication?

4 NKDA LEVALBUTEROL HYDROCHLORIDE Xopenex Treatment or prevention of bronchospasm in patients with reversible obstructive airway disease. Treatment of bronchospasms. Open up airway to allow patient to breathe better. Yes, patient was able to breathe better. Toxicity Body as a Whole: Allergic reactions, flu syndrome, pain. CNS: Migraine, dizziness, nervousness, tremor, anxiety. CV: Tachycardia. GI: Dyspepsia. Respiratory: Increased cough, viral infection, rhinitis, sinusitis, turbinate edema, paradoxical bronchospasm. Endocrine: Increase in serum glucose. Inhalation 0.31 mg by nebulization t.i.d. every 6–8 h (max: 0.63 mg every 6 hours) Yes, 0.63mg q6 hrs Monitor blood pressure, heart rate, and respiratory status. n/a Discontinue med immediately and notify physician if chest pains or palpitations, swelling of the eyelids, tongue, lips, or face; increased wheezing or difficulty breathing become present. Seek medical advice immediately if a previously effective dose becomes ineffective. Do not use drug more frequently than prescribed. Exercise caution with hazardous activities; dizziness and vertigo are possible side effects. Check with physician before taking OTC cold medication.

Rogers State University Associate Degree Nursing Program Required Drug Information Student name:

ERIN MCDANIEL

Date/ Clinical week:

11/02/2009- Week 2

Clinical faculty:

VAN GUNDY

Patient weight:

39.5#

Patient age: Patient allergies 1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects: Common adverse reactions/side effects:

5. 6. 7. 8.

9.

What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication?

12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

4 NKDA CEFTRIAXONE SODIUM Rocephin Infections caused by susceptible organisms in lower respiratory tract, skin and skin structures, urinary tract, bones and joints; also intra-abdominal infections, pelvic inflammatory disease, uncomplicated gonorrhea, meningitis, and surgical prophylaxis. Infections caused by susceptible organisms in lower respiratory tract To clear up pneumonia No, X-Ray showed negative interval chest impression on 11-0109. On 11-03-09 X-Ray showed developing Right Middle Lobe Pneumonitis. Toxicity Body as a Whole: Pruritus, fever, chills, pain, induration at IM injection site; phlebitis (IV site). GI: Diarrhea, abdominal cramps, pseudomembranous colitis, biliary sludge. Urogenital: Genital pruritus; moniliasis. 900-1350 mg/day in 2 divided doses No, 500 mg IVPB every 24 hours (under dose, Patient also receiving Zithromax. Determine history of hypersensitivity reactions to cephalosporins and penicillins and history of other allergies, particularly to drugs, before therapy is initiated. Note IV injection sites for signs of phlebitis (redness, swelling, pain). Watch for petechiae, ecchymotic areas, epistaxis, or any unexplained bleeding. Ceftriaxone appears to alter vitamin K– producing gut bacteria; therefore, hypoprothrombinemic bleeding may occur. Check for fever if diarrhea occurs. Incidence of antibiotic-produced pseudomembranous colitis is higher than with most cephalosporins. Culture and sensitivity tests before initiation of therapy and periodically during therapy. Initial culture and sensitivity results were not back. Discontinue med immediately and notify physician if hypersensitivity observed.

Report any signs of bleeding. Report loose stools or diarrhea promptly.

Rogers State University Associate Degree Nursing Program Required Drug Information Student name:

ERIN MCDANIEL

Date/ Clinical week:

11/02/2009- Week 2

Clinical faculty:

Mrs. VAN GUNDY

Patient weight:

39.5#

Patient age: Patient allergies

4 NKDA

1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

PREDNISONE n/a Used in treatment of myasthenia gravis and inflammatory conditions and as an immunosuppressant.

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects: Common adverse reactions/side effects:

As an immunosuppressant

5. 6. 7. 8.

9.

What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication? 12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

To build up patient’s immune system N/A, does not appear to be working since Patient’s status seems to have gotten worse. Toxicity CNS: Euphoria, headache, insomnia, confusion, psychosis. CV: CHF, edema. GI: Nausea, vomiting, peptic ulcer. Musculoskeletal: Muscle weakness, delayed wound healing, muscle wasting, osteoporosis, aseptic necrosis of bone, spontaneous fractures. Endocrine: Cushingoid features, growth suppression in children, carbohydrate intolerance, hyperglycemia. Special Senses: Cataracts. Hematologic: Leukocytosis. Metabolic: Hypokalemia. 18-36 mg/day Yes, 15mg/5ml Suspension> 5ml po BID Check and record BP during dose stabilization period at least 2 times daily. Report an ascending pattern. n/a Report any changes in mood and behavior, emotional stability, sleep pattern, or psychomotor activity to physician. Take drug as prescribed and do not alter dosing regimen or stop medication without consulting physician. Be aware that a slight weight gain with improved appetite is expected, but after dosage is stabilized, a sudden slow but steady weight increase [2 kg (5 lb) per wk] should be reported to physician. Report symptoms of GI distress to physician and do not self-medicate to find relief. Do

not use aspirin or other OTC drugs unless they are prescribed specifically by the physician.

Rogers State University Associate Degree Nursing Program Required Drug Information Student name: Date/ Clinical week: Clinical faculty: Patient weight: Patient age: Patient allergies 1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects:

5. 6. 7. 8.

Common adverse reactions/side effects: 9. What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication? 12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

/

Rogers State University Associate Degree Nursing Program Required Drug Information Student name: Date/ Clinical week: Clinical faculty: Patient weight: Patient age: Patient allergies 1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects:

5. 6. 7. 8.

Common adverse reactions/side effects: 9. What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication? 12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

/

Rogers State University Associate Degree Nursing Program Required Drug Information Student name: Date/ Clinical week: Clinical faculty: Patient weight: Patient age: Patient allergies 1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects:

5. 6. 7. 8.

Common adverse reactions/side effects: 9. What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication? 12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

/

Rogers State University Associate Degree Nursing Program Required Drug Information Student name: Date/ Clinical week: Clinical faculty: Patient weight: Patient age: Patient allergies 1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects:

5. 6. 7. 8.

Common adverse reactions/side effects: 9. What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication? 12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

/

Rogers State University Associate Degree Nursing Program Required Drug Information Student name: Date/ Clinical week: Clinical faculty: Patient weight: Patient age: Patient allergies 1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects:

5. 6. 7. 8.

Common adverse reactions/side effects: 9. What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication? 12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

/

Rogers State University Associate Degree Nursing Program Required Drug Information Student name: Date/ Clinical week: Clinical faculty: Patient weight: Patient age: Patient allergies 1. 2. 3.

Generic name of the drug: Trade name of the drug: Indications for use of the drug:

4.

For which of the above indications is your patient receiving the drug? Expected therapeutic effects of the drug for your patient: Has the drug produced the expected effect in this patient? How? Life threatening adverse reactions/side effects:

5. 6. 7. 8.

Common adverse reactions/side effects: 9. What is the normal dose range of the medication for this patient? 10. Is this patient's dose within the normal range? 11. What special nursing assessments are required for patients receiving this medication? 12. What lab tests are monitored related to use of this medication? 13. What special nursing interventions are required for patients receiving this medication? 14. What special teaching is required for patients receiving this medication?

/